Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Esophageal Squamous Cell Carcinoma × 130-nm albumin-bound paclitaxel × Clear all

Phase

Phase 2 8 Phase 1 3 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Thymoma 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Large Cell 1 Carcinoma 1 Advanced Gastric Cancer 1 Adenocarcinoma Pancreas 1 Adenocarcinoma 1

Interventions

Cisplatin 2 tislelizumab 1 Radiotherapy 1 Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06388135 2024-04-29

Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Xijing Hospital

Phase 4 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡